INFI - Infinity Pharmaceuticals Inc.
Close
0.03
-0.015 -49.000%
Share volume: 0
Last Updated: Wed 13 Sep 2023 07:59:14 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-03 | 2022-08-09 | 2022-11-14 | 2023-03-28 | 2023-05-09 | |
| Total revenue | 652.000 K | 686.000 K | 712.000 K | 543.000 K | 731.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 652.000 K | 686.000 K | 712.000 K | 543.000 K | 731.000 K | |
| 5.21% | 3.79% | -23.74% | 34.62% | |||
| Operating expenses | 12.666 M | 12.290 M | 11.164 M | 9.754 M | 11.797 M | |
| Selling general and admin | 3.676 M | 3.495 M | 3.501 M | 2.791 M | 5.944 M | |
| Research and development | 8.990 M | 8.795 M | 7.663 M | 6.963 M | 5.853 M | |
| Total expenses | 13.059 M | 12.704 M | 11.593 M | 10.081 M | 12.238 M | |
| -2.72% | -8.75% | -13.04% | 21.40% | |||
| Operating income | -12.407 M | -12.018 M | -10.881 M | -9.538 M | -11.507 M | |
| Ebit | -12.407 M | -12.018 M | -10.881 M | -9.538 M | -11.507 M | |
| Pretax income | -12.436 M | -11.986 M | -10.717 M | -9.230 M | -11.045 M | |
| -3.62% | -10.59% | -13.88% | 19.66% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -12.436 M | -11.986 M | -10.717 M | -9.230 M | -11.045 M | |
| 3.62% | 10.59% | 13.88% | -19.66% | |||
| Net income | -12.436 M | -11.986 M | -10.717 M | -9.230 M | -11.045 M | |
| 3.62% | 10.59% | 13.88% | -19.66% |